Evorpacept
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Evorpacept, covering 2025-01-13 to 2026-07-22. Get the full timeline:
Most recent: Clinical Trial Results: Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer [Phase 2]